Lynne Nakashima

6PUBLICATIONS
14CO-AUTHORS
Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 03, 2026
Real-world effectiveness of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and advanced melanoma at BC Cancer.

Ruishen Yu, Kiran Gill, Shirley St Yeung

|Sep 01, 2023
Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer.

Jennifer Truong, Shirley S T Yeung, Victoria Kletas

|Apr 06, 2022
International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions.

Andrew Walker, Alexandre Chan, Constanza Cortés Labra

|Mar 07, 2022
Real-world incidence of venetoclax toxicities in British Columbia.

Cassandra Lee, Adeline Markarian, Fatima Ladha

|Oct 06, 2021
Barriers and facilitators for the safe handling of antineoplastic drugs.

Sajjad S Fazel, Anya Keefe, Arshiya Shareef

|Jun 17, 2020
A real-world data approach to determine the optimal dosing strategy for pembrolizumab.

Ashley Jang, Lynne Nakashima, Tonya Ng

Pageof 1

Frequent Collaborators

3 joint publications

Mario L de Lemos

2 joint publications

Victoria Kletas

2 joint publications

Shirley St Yeung

2 joint publications

Jennifer Truong